生殖遗传学实验室可能影响整倍体囊胚率与活产率:4家美国实验室对玻璃化供卵子来源胚胎的PGT-A结果比较
这项2016至2020年的回顾性队列研究利用供卵子数据库,比较4家美国生殖遗传学实验室对玻璃化供卵子来源囊胚的PGT-A结果,共纳入2633枚胚胎。A实验室的整倍体囊胚率(73.6%)显著高于B(63.3%)、C(60.9%)和D(52.3%),A实验室每次整倍体移植的活产率(58.73%)也显著高于D实验室(47.3%)。作者认为在控制卵子质量后,不同PGT-A实验室的整倍体率和活产率存在差异,需进一步研究实验室技术与生物信息学算法。
要点
- A实验室整倍体囊胚率73.6%,显著高于B(63.3%)、C(60.9%)和D(52.3%)。
- B(2.8%)和C(5.5%)的嵌合体率显著低于A(9.9%)和D(11.5)。
- A实验室每次整倍体移植活产率58.73%,显著高于D实验室47.3%。
核心结论
- 在这项控制卵子质量的大型研究中,部分PGT-A实验室报告的整倍体囊胚率显著更高,同时活产率也更高。
- 作者认为此类比较有助于了解PGT-A过程对结局的作用,需进一步研究实验室技术和生物信息学算法的差异。
研究设计与样本
- 2016至2020年的回顾性队列研究,数据来自供卵子数据库。
- 纳入接受供卵子体外受精的患者,排除子宫因素、男性因素或手术取精者;仅接受健康且小于34岁的女性作为卵子供者。
- 采用下一代测序平台进行染色体分析,共纳入2633枚胚胎,4家实验室检测的胚胎数均超过200枚。
主要发现
- A实验室整倍体囊胚率73.6%,显著高于B实验室63.3%、C实验室60.9%和D实验室52.3%。
- B实验室嵌合体率2.8%、C实验室5.5%,均显著低于A实验室9.9%和D实验室11.5%。
- A实验室每次整倍体移植活产率58.73%,显著高于D实验室47.3%。
- 各实验室间着床率或流产率无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate potential variation in the euploid blastocyst rate and live birth rate (LBR) per single frozen euploid blastocyst transfer, among 4 unique United States reproductive genetics laboratories. Analyses were limited to blastocysts derived from vitrified donor oocytes, to minimize variation in oocyte quality. DESIGN: Retrospective cohort study from 2016 to 2020. SETTING: Donor Egg Bank Database. PATIENT(S): Patients undergoing in vitro fertilization with donor oocytes. We excluded patients with uterine factor, male factor, or surgically extracted sperm. Only healthy women <34 years old were accepted as oocyte donors. INTERVENTION(S): Next generation sequencing platforms for chromosomal analysis MAIN OUTCOME MEASURE(S): Euploid blastocyst rate and LBR per euploid transfer. Secondary outcomes included the rate of aneuploidy, mosaic calls, biochemical pregnancy loss, and miscarriage rate. RESULT(S): A total of 2,633 embryos were included. Four laboratories had >200 embryos tested. Euploid blastocyst rate was significantly higher in laboratory A (73.6%) vs. B (63.3%), C (60.9%), and D (52.3%). Mosaic rate was significantly lower for Laboratories B (2.8%) and C (5.5%) vs. Laboratories A (9.9%) and D (11.5). The LBR was significantly higher in laboratory A (58.73%) vs. laboratory D (47.3%). There were no significant differences in the implantation or miscarriage rate among laboratories. CONCLUSION(S): In this large study, controlling for oocyte quality, some preimplantation genetic testing for aneuploidy (PGT-A) laboratories report a significantly higher euploid blastocyst rate with concurrent higher LBR. This type of comparison is important as it provides insight into the role of the PGT-A process in outcomes. Further research is needed to evaluate the differences in laboratory techniques and bioinformatic algorithms accounting for variable outcomes across PGT-A laboratories.
引用
- Bardos J, Kwal J, Caswell W, et al. Reproductive genetics laboratory may impact euploid blastocyst and live birth rates: a comparison of 4 national laboratories' PGT-A results from vitrified donor oocytes. Fertil Steril. 2022. PMID: 36460523. doi:10.1016/j.fertnstert.2022.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。